Pancreatic cancer is advanced when it is unresectable, or can’t be removed by surgery. The cancer has spread to nearby blood vessels or lymph nodes, somewhat outside the pancreas or to distant organs ...
For the most common type of pancreatic cancer, pancreatic ductal adenocarcinoma, more than 90% of tumors are thought to have a KRAS mutation. For decades, these mutations were considered “undruggable, ...
Joining the Board this year is Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum, a leading health solution and care delivery organization. Mahrt brings a deep ...
Editor’s note: It’s been 12 years since the passing of Steve Jobs. This blog, published two years ago, discusses the rare form of pancreatic cancer Jobs had, pancreatic neuroendocrine tumor. It’s been ...
American Cancer Society’s Cancer Facts & Figures 2023, released today, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year.
LOS ANGELES, Calif. – (January 13, 2026) – Pancreatic cancer remains the third-leading cause of cancer-related deaths in the United States, behind lung and colorectal cancers. According to the ...
The administration’s fiscal year 2026 proposed budget included devastating cuts to the National Institutes of Health (NIH) and National Cancer Institute (NCI). In response, and as Congress returns to ...
July 1, 2021 marks 30 years since the beloved actor, writer and director Michael Landon – best known for playing Little Joe Cartwright on “Bonanza,” Charles (Pa) Ingalls on “Little House on the ...
Pancreatic cancer at any stage can create challenges in a patient’s diet and change nutritional needs. In recognition of June as National Fresh Fruit and Vegetable Month, we asked Maria Petzel, senior ...
Editor’s note: Each week, our Friday Fix series offers pancreatic cancer patients and caregivers a new topic related to health, diet and nutrition. For today’s post, we highlight healthy foods that ...
The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...
For eligible patients, surgery is the best option for long term survival of pancreatic cancer. Data show high volume surgeons at high volume hospitals have greater success rates and fewer ...